Allakos
Presence
Allakos is one of the...
Allakos is a company listed under the stock ticker ALLK (US).
Executives
View the org chart displaying its 15 main executives
Most searched biographies at Allakos
- Robert Alexander, Chief Executive Officer and Director
- Daniel Janney, Chairman of the Board
- Steven James, Director
Popular executive movements at Allakos
- Neil Graham has joined the company as Director (posted on September 1 2023).
- Dolca Thomas has joined the company as Director (posted on August 3 2023).
- Rand Sutherland has joined the company as Director (posted on August 3 2023).
Create your alert
to follow the executive moves at Allakos.
Biotechnology
Allakos has 2,281 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
- Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
- Histogen has filed for bankruptcy protection (posted on April 19 2024).
Popular contacts in Biotechnology
News
Press releases by Allakos
- Allakos Announces the Appointment of Dr. Amy Ladd to its Board of Directors | Allakos
- Allakos Provides Business Update and Reports First Quarter 2022 Financial Results | Allakos
- Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results | Allakos
- Allakos to Host Investor Day on February 15 | Allakos
- Allakos Announces Publication of Results from the Phase 2 Study of Lirentelimab (AK002) in Patients with Eosinophilic Gastritis and/or Eosinophilic Duodenitis (ENIGMA) in the New England Journal of Medicine | Allakos
- Allakos Reports Second Quarter 2020 Financial Results and Provides Business Update | Allakos
- Allakos Initiates Patient Recruitment for AK002 Registrational Studies | Allakos
- Allakos Announces Multiple Presentations Related to Eosinophil and Mast Cell-Driven Diseases at the Digital EAACI Annual Congress 2020 | Allakos
- Allakos Reports First Quarter 2020 Financial Results | Allakos
- Allakos Announces a Presentation of Antolimab in Patients with Severe Allergic Conjunctivitis at the 2020 ASCRS Virtual Annual Meeting | Allakos
- View more press releases Close
Social media about Allakos
- Allakos on Wikipedia, Google News & Yahoo Finance
- Allakos on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Robert Alexander 
